Literature DB >> 10585418

Constitutive G(i2)-dependent activation of adenylyl cyclase type II by the 5-HT1A receptor. Inhibition by anxiolytic partial agonists.

P R Albert1, N Sajedi, S Lemonde, M H Ghahremani.   

Abstract

The 5-HT1A receptor is implicated in depression and anxiety. This receptor couples to G(i) proteins to inhibit adenylyl cyclase (AC) activity but can stimulate AC in tissues (e.g. hippocampus) that express ACII. The role of ACII in receptor-mediated stimulation of cAMP formation was examined in HEK-293 cells transfected with the 5-HT1A receptor, which mediated inhibition of basal and G(s)-induced cAMP formation in the absence of ACII. In cells cotransfected with 5-HT1A receptor and ACII plasmids, 5-HT1A agonists induced a 1. 5-fold increase in cAMP level. Cotransfection of 5-HT1A receptor, ACII, and Galpha(i2), but not Galpha(i1), Galpha(i3), or Galpha(o), resulted in an agonist-independent 6-fold increase in the basal cAMP level, suggesting that G(i2) preferentially coupled the receptor to ACII. The 5-HT1B receptor also constitutively activated ACII. Constitutive activity of the 5-HT1A receptor was blocked by pertussis toxin and the Gbetagamma antagonist, betaCT, suggesting an important role for Gbetagamma-mediated activation of ACII. The Thr-149 --> Ala mutation in the second intracellular domain of the 5-HT1A receptor disrupted Gbetagamma-selective activation of ACII. Spontaneous 5-HT1A receptor activity was partially attenuated by 5-HT1A receptor partial agonists with anxiolytic activity (e.g. buspirone and flesinoxan) but was not altered by full agonists or antagonists. Thus, anxiolytic activity may involve inhibition of spontaneous 5-HT1A receptor activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585418     DOI: 10.1074/jbc.274.50.35469

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity.

Authors:  F Y Carroll; A Stolle; P M Beart; A Voerste; I Brabet; F Mauler; C Joly; H Antonicek; J Bockaert; T Müller; J P Pin; L Prézeau
Journal:  Mol Pharmacol       Date:  2001-05       Impact factor: 4.436

2.  Further characterization of 5-HT1A receptors in the goldfish retina: role of cyclic AMP in the regulation of the in vitro outgrowth of retinal explants.

Authors:  C Schmeer; F Obregón; M Urbina; L Lima
Journal:  Neurochem Res       Date:  2001-03       Impact factor: 3.996

3.  TNFAIP8: a new effector for Galpha(i) coupling to reduce cell death and induce cell transformation.

Authors:  Benoit Laliberté; Ariel M Wilson; Houman Nafisi; Helen Mao; Yi Yuen Zhou; Mireille Daigle; Paul R Albert
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

4.  A critical protein kinase C phosphorylation site on the 5-HT(1A) receptor controlling coupling to N-type calcium channels.

Authors:  X Wu; N Kushwaha; P R Albert; N J Penington
Journal:  J Physiol       Date:  2002-01-01       Impact factor: 5.182

5.  Modifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy.

Authors:  Paul R Albert; Brice Le François
Journal:  Front Neurosci       Date:  2010-06-17       Impact factor: 4.677

Review 6.  Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor.

Authors:  Jieon Lee; Diana Avramets; Byungsun Jeon; Hyunah Choo
Journal:  Molecules       Date:  2021-06-02       Impact factor: 4.411

Review 7.  How much do we know about the coupling of G-proteins to serotonin receptors?

Authors:  Matteo Giulietti; Viviana Vivenzio; Francesco Piva; Giovanni Principato; Cesario Bellantuono; Bernardo Nardi
Journal:  Mol Brain       Date:  2014-07-10       Impact factor: 4.041

Review 8.  What Do We Really Know About 5-HT1A Receptor Signaling in Neuronal Cells?

Authors:  Paulina S Rojas; Jenny L Fiedler
Journal:  Front Cell Neurosci       Date:  2016-11-24       Impact factor: 5.505

9.  The functional cooperation of 5-HT1A and mGlu4R in HEK-293 cell line.

Authors:  Grzegorz Burnat; Piotr Brański; Joanna Solich; Magdalena Kolasa; Barbara Chruścicka; Marta Dziedzicka-Wasylewska; Andrzej Pilc
Journal:  Pharmacol Rep       Date:  2020-05-29       Impact factor: 3.024

10.  Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.

Authors:  Francis E Lotrich; Bruce G Pollock
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.